Assessment of the real-world safety profile of vedolizumab using the United States Food and Drug Administration adverse event reporting system
Abstract
- Publication:
-
PLoS ONE
- Pub Date:
- December 2019
- DOI:
- 10.1371/journal.pone.0225572
- Bibcode:
- 2019PLoSO..1425572C